C-reactive protein and atrial fibrillation:: "Evidence for the presence of inflammation in the perpetuation of the arrhythmia"

被引:43
作者
Acevedo, M
Corbalán, R
Braun, S
Pereira, J
Navarrete, C
Gonzalez, I
机构
[1] Catholic Univ Chile, Dept Cardiovasc Dis, Santiago, Chile
[2] Catholic Univ Chile, Dept Thrombosis & Hemostasis, Santiago, Chile
关键词
atrial fibrillation; C-reactive protein; inflammation;
D O I
10.1016/j.ijcard.2005.05.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Atrial fibrillation (AF) is associated to a high risk of systemic embolism. The mechanisms that contribute to thrombogenesis in these patients are still poorly understood. Systemic and/or local inflammation could be involved in the process of thrombogenesis and contribute to the perpetuation of the arrhythmia. The purpose of the study was to evaluate the role of inflammation and its relation to thrombogenesis and cardiac rhythm in AF. Methods: We prospectively studied 130 patients with newly diagnosed non-valvular AF in absence of antithrombotic therapy. Determinations of C-reactive protein (CRP) and thrombin-antithrombin complex (TAT) plasma levels, along with a transesophageal echocardiogram were performed in all the patients at admission. Results: Mean age of the group was 67 14 years. CRP levels were significantly elevated in AF patients versus controls (matched by age, gender and cardiovascular risk factors) (1.0 +/- 1.8 versus 0.3 +/- 0.4 mg/dl, respectively, p < 0.01). Baseline TAT levels were also significantly elevated in AF patients but no correlation was found between CRP and TAT. At 1-year of follow-up, mean CRY levels were still elevated in patients that remained in AF compared to those who converted to sinus rhythm (1.2 +/- 1.8 compared to 0.5 +/- 1.5 mg/dl, p = 0.03). CRP was the only biochemical predictor of sinus rhythm maintenance at I-year follow-up independently of clinical (including adjustment for risk factors and antiarrhythmic drugs), biochemical and echo parameters. Conclusions: There is evidence for the presence of inflammation in patients with non-valvular AF, which is not related to activation of the coagulation cascade. The persistence of inflammation is associated with chronic AF at I-year follow up. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:326 / 331
页数:6
相关论文
共 27 条
[1]   PREDICTORS OF THROMBOEMBOLISM IN ATRIAL-FIBRILLATION .1. CLINICAL-FEATURES OF PATIENTS AT RISK [J].
ANDERSON, DC ;
ASINGER, RW ;
NEWBURG, SM ;
FARMER, CC ;
WANG, K ;
BUNDLIE, SR ;
KOLLER, RL ;
JAGIELLA, WM ;
KREHER, S ;
JORGENSEN, CR ;
SHARKEY, SW ;
FLAKER, GC ;
WEBEL, R ;
NOLTE, B ;
STEVENSON, P ;
BYER, J ;
WRIGHT, W ;
CHESEBRO, JH ;
WIEBERS, DO ;
HOLLAND, AE ;
MILLER, DM ;
BARDSLEY, WT ;
LITIN, SC ;
MEISSNER, I ;
ZERBE, DM ;
MCANULTY, JH ;
MARCHANT, C ;
COULL, BM ;
FELDMAN, G ;
HAYWARD, A ;
GANDARA, E ;
MACMILLAN, K ;
BLANK, N ;
LEONARD, AD ;
KANTER, MC ;
ISENSEE, LM ;
QUIROGA, ES ;
PRESTI, CH ;
TEGELER, CH ;
LOGAN, WR ;
HAMILTON, WP ;
GREEN, BJ ;
BACON, RS ;
REDD, RM ;
CADELL, DJ ;
GOMEZ, CR ;
JANOSIK, DL ;
LABOVITZ, AJ ;
KELLEY, RE ;
CHAHINE, R .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (01) :1-5
[2]   Inflammation as a risk factor for atrial fibrillation [J].
Aviles, RJ ;
Martin, DO ;
Apperson-Hansen, C ;
Houghtaling, PL ;
Rautaharju, P ;
Kronmal, RA ;
Tracy, RP ;
Van Wagoner, DR ;
Psaty, BM ;
Lauer, MS ;
Chung, MK .
CIRCULATION, 2003, 108 (24) :3006-3010
[3]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[4]  
Bruins P, 1997, CIRCULATION, V96, P3542
[5]   Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation [J].
Carnes, CA ;
Chung, MK ;
Nakayama, T ;
Nakayama, H ;
Baliga, RS ;
Piao, S ;
Kanderian, A ;
Pavia, S ;
Hamlin, RL ;
McCarthy, PM ;
Bauer, JA ;
Van Wagoner, DR .
CIRCULATION RESEARCH, 2001, 89 (06) :E32-E38
[6]   C-reactive protein elevation in patients with atrial arrhythmias - Inflammatory mechanisms and persistence of atrial fibrillation [J].
Chung, MK ;
Martin, DO ;
Sprecher, D ;
Wazni, O ;
Kanderian, A ;
Carnes, CA ;
Bauer, JA ;
Tchou, PJ ;
Niebauer, MJ ;
Natale, A ;
Van Wagoner, DR .
CIRCULATION, 2001, 104 (24) :2886-2891
[7]   Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation [J].
Conway, DSG ;
Buggins, P ;
Hughes, E ;
Lip, GYH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (11) :2075-2082
[8]   Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation [J].
Dernellis, J ;
Panaretou, M .
EUROPEAN HEART JOURNAL, 2004, 25 (13) :1100-1107
[9]   C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation [J].
Dernellis, J ;
Panaretou, M .
ACTA CARDIOLOGICA, 2001, 56 (06) :375-380
[10]   Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients [J].
Di Napoli, M ;
Papa, F .
STROKE, 2002, 33 (07) :1763-1771